You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 201501 - 201510 of 207728 results
  1. FY 2013 Contract HHSN271201300012C, SBIR-1, Topic 003, Automated Instrument for C

    SBC: CODEX BIOSOLUTIONS            Topic: NIDA

    In this SBIR phase I grant application, Codex BioSolutions proposes to construct a cell-based high throughput assay that measures chemical toxicity using a novel dye, m-MPI. This dye was engineered to overcome many of the drawbacks of current dyes used tomeasure mitochondrial membrane potential. The parent dye JC-1 has been used for this purpose previously. In the mitochondria, where it accumulat ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  2. IGF::OT::IGF Contract Award to Care Team Solutions, LLC: Using mHealth to Aid Opi

    SBC: CARE TEAM SOLUTIONS, LLC            Topic: NIDA

    Opiate-agonist pharmacotherapy utilizing buprenorphine/naloxone is known to decrease illicit opiate use. However, poor medication management and misuse during self-managed opioid substitution therapy (OST) constrains efficacy, while aggrandizing relapse,hospitalizations and mortality. One of the most inescapable challenges confronted by professionals treating opioid dependence (OD) is assuring ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  3. IFG::OT::IFG: At-Home Prescription Drug Disposal System N43DA-13-4421. Period o

    SBC: GINER INC            Topic: NIDA

    Objective: Demonstrate effectiveness of a safe, immediate, cost-effective, ecological, and user-friendly system that enables at-home deactivation and disposal of psychoactive prescription pharmaceuticals. Giner, Inc. proposes to develop a miniaturized electrolytic mixed-oxidant (MOX) system to safely destroy psychoactive pharmaceuticals in solid, liquid or patch form. The proposed system is design ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  4. IGF::OT::IGF Mobile App to Improve Medication Adherence in Adults with Prescripti

    SBC: RINGFUL LLC            Topic: NIDA

    The Contractor will develop and validate mobile phone-based interventions to improve prescription medication adherence based on each patient's individual preferences and traits. PUBLIC HEALTH RELEVANCE

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  5. IGF::OT::IGF Med-Check- Medication Adherence System; POP 8/29/13- 2/28/2014; FY

    SBC: COG ANALYTICS, LLC            Topic: NIDA

    The Contractor will design, develop, and evaluate the MedCheck prototype - a comprehensive web and mobile integrated, medication adherence system. PUBLIC HEALTH RELEVANCE

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  6. mSMART: Mobile App based Personalized Solutions and Tools for for Medication Adhe

    SBC: Intelligent Automation, Inc.            Topic: NIDA

    The proposed research is about developing a mobile app-based solution called mSMART (Mobile App-based Personalized Solutions and Tools for Medication Adherence of Rx Pill), and evaluating the solution using human subject-based pilot studies. PUBLIC HEALTHRELEVANCE

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  7. IGF::OT::IGF: IN-HOME DEACTIVATION SYSTEM FOR PSYCHOACTIVE DRUGS. N43DA-13-4420.

    SBC: Verde Environmental Technologies, Inc.            Topic: NIDA

    Under this Small Business Innovation Research (SBIR) Phase I project, Reasearch Topic 148, the Contractor will develop an inexpensive in-home product for rapid and safe at-source deactivation of discarded psychoactive pharmaceuticals. PUBLIC HEALTH RELEVANCE

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  8. IGF::OT::IGF: FY13: Phenotypic Screening of Smoking Cessation Drugs, N43DA-13-7

    SBC: AFASCI, INC.            Topic: NIDA

    Under this Small Business Innovation Research (SBIR) Phase I project, Research Topic 149, the Contractor shall develop predictive in vivo screening systems for phenotypic drug discovery for smoking cessation. The Contractor shall accomplish this throughthe following objectives: Objective 1- Evaluate a battery of tests aimed at examining various components of nicotine addiction to be used for p ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  9. ICET, Inc.

    SBC: ICET, INC            Topic: NIDA

    Objective 1: In this objective, the Contractor shall obtain the pure and pharmaceutical forms of codeine, morphine, oxycodone and fentanyl from DEA-certified commercial distributor(s) as well as other materials required for testing of the kit. The Contractor shall also identify parameters for the degradation of the pure and pharmaceutical forms of these drugs. Objective 2: In this objective, th ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  10. IGF::OT::IGF: SBIR TT- Transcatheter Cerclage Mitral Valve Annulopasty for Secon

    SBC: MYTECH MEDICAL, INC.            Topic: NHLBI

    The purpose of this research is to evaluate the feasibility of transcatheter based mitral valve annuloplasty for correcting secondary mitral valve regurgitation. Few transcatheter based therapy for the treatment of mitral regurgitation has emerged rapidlyover the past few years. These methods implant the device via Coronary Sinus. Although some of the systems showed potential a major obstacle is c ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government